Pulmatrix, Inc. ( PULM) - Stock Earnings
PULM Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
PULM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -928000 USD | — USD |
| 2026Q1 | -1.2 million USD | — USD |
| 2026Q2 | -1.0 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
PULM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -14.1 million USD | 7.3 million USD |
| 2024 | -9.6 million USD | 7.8 million USD |
| 2025 | -5.2 million USD | — USD |
| 2026 Est. | — | — |
PULM
Price: $1.44
52 week price:
Earnings Per Share: -1.10 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 23200
Ebitda: -4.2 millionMarket Capitalization: 5.3 million